- Advertisement -
Researchers have found a way to program immune cells to attack glioblastoma and treat the inflammation of multiple sclerosis in mice. The technology will soon be tested in a clinical trial for people with glioblastoma.
UCSF scientists have developed a “molecular GPS” to guide immune cells into…
